Patents by Inventor Jin Ding
Jin Ding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12112722Abstract: An adaptive adjustment system and method for the brightness of a holographic waveguide display device is provided. The adaptive adjustment system includes five functional modules: a computer control module, a driving and adjustment module, a micro image source display module, an optical waveguide transmission module and an ambient light acquisition module. A video signal is provided by the computer control module and is then transmitted under the control of the driving and adjustment module to illuminate the micro image source display module, and light information of the micro image source display module is finally transmitted to human eyes by means of the optical waveguide transmission module to realize display. The ambient light acquisition module is used for acquiring environmental illuminance information and transmitting the environmental illuminance information to the driving and adjustment module to change the brightness of the micro image source display module.Type: GrantFiled: December 29, 2022Date of Patent: October 8, 2024Assignee: SOUTHEAST UNIVERSITYInventors: Yuning Zhang, Zhuang Liu, Jin Ding
-
Publication number: 20240331658Abstract: An adaptive adjustment system and method for the brightness of a holographic waveguide display device is provided. The adaptive adjustment system includes five functional modules: a computer control module, a driving and adjustment module, a micro image source display module, an optical waveguide transmission module and an ambient light acquisition module. A video signal is provided by the computer control module and is then transmitted under the control of the driving and adjustment module to illuminate the micro image source display module, and light information of the micro image source display module is finally transmitted to human eyes by means of the optical waveguide transmission module to realize display. The ambient light acquisition module is used for acquiring environmental illuminance information and transmitting the environmental illuminance information to the driving and adjustment module to change the brightness of the micro image source display module.Type: ApplicationFiled: December 29, 2022Publication date: October 3, 2024Applicant: SOUTHEAST UNIVERSITYInventors: Yuning ZHANG, Zhuang LIU, Jin DING
-
Publication number: 20240307564Abstract: The present disclosure provides herein conjugates of anti-CLDN18.2 antibodies or antigen-binding fragments thereof with radionuclides, the pharmaceutical composition containing the same and the uses thereof in imaging, patient screening, treatment process monitoring and efficacy evaluation.Type: ApplicationFiled: February 18, 2022Publication date: September 19, 2024Inventors: Xueming QIAN, Hua ZHU, Fei TENG, Hongjun LI, Zhi YANG, Yi GU, Jin DING, Feng WANG
-
Publication number: 20240299495Abstract: A stabilized aPGF composition or a method for stabilization of the pharmaceutical composition comprising aFGF are provided. The composition comprises aPGF, a citric acid compound and other excipients. The method for improving stability of aPGF in the form of a liquid formulation or a lyophilized formulation so as to increase storage stability is also provided.Type: ApplicationFiled: May 28, 2024Publication date: September 12, 2024Applicant: EUSOL BIOTECH CO., LTD.Inventor: Jin-Ding HUANG
-
Patent number: 11638892Abstract: A high-adsorption-performance nanofiber filter medium includes a support material and a composite nanofiber filtration layer that includes multiple nanometer composite nanofiber layers deposited and stacked on the support material. The nanometer composite nanofiber layer includes first, second, and third nano-powder composite nanofibers, which are uniformly mixed by means of an airflow or are sequentially laminated to form the nanometer composite nanofiber layer. The nanometer composite nanofiber layer formed through sequential lamination includes first, second, and third nanofiber layers. The first nanofiber layer includes multiple first nano-powder composite nanofibers. The second nanofiber layer is stacked on the first nanofiber layer and includes multiple second nano-powder composite nanofibers. The third nanofiber layer is stacked on the second nanofiber layer and includes multiple third nano-powder composite nanofibers.Type: GrantFiled: July 21, 2020Date of Patent: May 2, 2023Assignee: CHANG-FONG TEXTILE TECHNOLOGY CO., LTD.Inventor: Jin-Ding Chen
-
Publication number: 20220152153Abstract: A stabilized aFGF composition or a method for stabilization of the pharmaceutical composition comprising aFGF are provided. The composition comprises aFGF, a citric acid compound and other excipients. The method for improving stability of aFGF in the form of a liquid formulation or a lyophilized formulation so as to increase storage stability is also provided.Type: ApplicationFiled: November 15, 2021Publication date: May 19, 2022Applicant: EUSOL BIOTECH CO., LTD.Inventor: Jin-Ding HUANG
-
Publication number: 20220071987Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.Type: ApplicationFiled: September 22, 2021Publication date: March 10, 2022Inventors: Chan-Jung LI, David Chih-Kuang CHOU, Jin-Ding HUANG, Shin-Jr TSAI, Shu-Wen KUO, Yu-En TIEN
-
Patent number: 11241424Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.Type: GrantFiled: December 30, 2019Date of Patent: February 8, 2022Assignees: Lumosa Therapeutics Co., Ltd., Shanghai Lumosa Therapeutics Co., Ltd.Inventors: Chan-Jung Li, David Chih-Kuang Chou, Jin-Ding Huang, Shin-Jr Tsai, Shu-Wen Kuo, Yu-En Tien
-
Patent number: 11234974Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.Type: GrantFiled: November 19, 2018Date of Patent: February 1, 2022Assignees: Lumosa Therapeutics Co., Ltd., Shanghai Lumosa Therapeutics Co., Ltd.Inventors: Chan-Jung Li, David Chih-Kuang Chou, Jin-Ding Huang, Shin-Jr. Tsai, Shu-Wen Kuo, Yu-En Tien
-
Publication number: 20220023783Abstract: A high-adsorption-performance nanofiber filter medium includes a support material and a composite nanofiber filtration layer that includes multiple nanometer composite nanofiber layers deposited and stacked on the support material. The nanometer composite nanofiber layer includes first, second, and third nano-powder composite nanofibers, which are uniformly mixed by means of an airflow or are sequentially laminated to form the nanometer composite nanofiber layer. The nanometer composite nanofiber layer formed through sequential lamination includes first, second, and third nanofiber layers. The first nanofiber layer includes multiple first nano-powder composite nanofibers. The second nanofiber layer is stacked on the first nanofiber layer and includes multiple second nano-powder composite nanofibers. The third nanofiber layer is stacked on the second nanofiber layer and includes multiple third nano-powder composite nanofibers.Type: ApplicationFiled: July 21, 2020Publication date: January 27, 2022Inventor: JIN-DING CHEN
-
Patent number: 10946062Abstract: Disclosed are methods and compositions useful in preventing or treating a metabolic disorder by using a protein having an amino acid sequence as set forth in SEQ ID NO: 1.Type: GrantFiled: February 26, 2020Date of Patent: March 16, 2021Assignee: EUSOL BIOTECH CO., LTD.Inventors: Jin-Ding Huang, Wan-Ya Chang, Che-Ming Yeh
-
Patent number: 10806877Abstract: A portable breathing machine includes a body case (100), wherein: a fan box (101), a cut-off device (108) and a control device (113) are arranged in the body case (100); a fan (8) is arranged in the fan box (101) through a fan noise reduction device (102); an air outlet of the fan box (101) is connected with an internal breathing tube (107); the cut-off device (108) is arranged on the internal breathing tube (107); an air outlet of the cut-off device (108) is connected with an external breathing tube (104) and a mask (105); the fan noise reduction device (102) includes a lower flexible cover (3) and an upper flexible cover (5); the lower and upper flexible covers cooperate to form an enclosed cavity for containing the fan (8). A working noise of the breathing machine is decreased to below 15 decibel.Type: GrantFiled: March 22, 2016Date of Patent: October 20, 2020Assignee: MICOMME MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD.Inventors: Zheng Dai, Jin Ding, Wei Liu, Qinpeng Xu, Haoxuan Huang, Weili Li, Chao He, Menghang Lei, Xiaohui Zeng, Guangrong Wang
-
Publication number: 20200276264Abstract: Disclosed are methods and compositions useful in preventing or treating a metabolic disorder by using a protein having an amino acid sequence as set forth in SEQ ID NO: 1.Type: ApplicationFiled: February 26, 2020Publication date: September 3, 2020Applicant: Eusol Biotech Co., Ltd.Inventors: Jin-Ding Huang, Wan-Ya Chang, Che-Ming Yeh
-
Publication number: 20200179373Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.Type: ApplicationFiled: February 18, 2020Publication date: June 11, 2020Inventors: Chan-Jung LI, David Chih-Kuang CHOU, Jin-Ding HUANG, Shin-Jr TSAI, Shu-Wen KUO, Yu-En TIEN
-
Publication number: 20200179372Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.Type: ApplicationFiled: December 30, 2019Publication date: June 11, 2020Inventors: Chan-Jung LI, David Chih-Kuang CHOU, Jin-Ding HUANG, Shin-Jr TSAI, Shu-Wen KUO, Yu-En TIEN
-
Publication number: 20200030318Abstract: The present invention relates to kits and prefilled syringes comprising pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as methods of treating pain using such formulations.Type: ApplicationFiled: September 30, 2019Publication date: January 30, 2020Inventors: Chan-Jung LI, David Chih-Kuang CHOU, Jin-Ding HUANG, Shin-Jr TSAI, Shu-Wen KUO, Yu-En TIEN
-
Patent number: 10407886Abstract: The present invention includes a toilet pool, wherein the toilet pool has a pool tapered from top to bottom, the bottom of the pool is a discharge outlet, the top of the pool is a tapered annular platform, the tapered annular platform consists of a wide part and a narrow part, above the tapered annular platform is a slot flush nozzle, shunts implemented by the slot flush nozzle are evenly distributed on a surface of the pool under the guide of the tapered annular platform, and the toilet pool is provided with a clean water supply. It achieves a configuration that two flushing systems coexist on a toilet pool, achieves secondary homogenization of water currents, achieves water-saving and efficient flushing, achieves maximization of water capacity in the same space, and achieves a simple, reliable fixedly-installed toilet.Type: GrantFiled: November 6, 2015Date of Patent: September 10, 2019Assignee: QINGDAO CHUANGHUI INDUSTRY CO., LTD.Inventors: Limin Ding, Jinghe Wang, Jinning Ding, Guifen Bai
-
Patent number: 10355340Abstract: A lighting device is disclosed. The lighting device comprises: a solid-state lighting element; a radio frequency communication unit for wireless communication between the lighting device and an external device; a light guide having a circumferential edge, wherein the light guide is adapted to couple in light emitted by the solid-state lighting element and to provide illumination to the surroundings of the lighting device; and a metal strip extending along at least a portion of the circumferential edge of the light guide, wherein the metal strip is in thermal contact with the solid-state lighting element and the light guide, and wherein the metal strip is coupled to the radio frequency communication unit so as to operate as an antenna for the radio frequency communication unit.Type: GrantFiled: May 25, 2017Date of Patent: July 16, 2019Assignee: SIGNIFY HOLDING B.V.Inventors: Antonius Adrianus Maria Marinus, Yacouba Louh, Jin Ding
-
Publication number: 20190160053Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.Type: ApplicationFiled: November 19, 2018Publication date: May 30, 2019Inventors: Chan-Jung LI, David Chih-Kuang Chou, Jin-Ding Huang, Shin-Jr Tsai, Shu-Wen Kuo, Yu-En Tien
-
Patent number: 10183018Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.Type: GrantFiled: May 27, 2016Date of Patent: January 22, 2019Assignees: Lumosa Therapeutics Co., Ltd., Shanghai Lumosa Therapeutics Co., Ltd.Inventors: Chan-Jung Li, David Chih-Kuang Chou, Jin-Ding Huang, Shin-Jr. Tsai, Shu-Wen Kuo, Yu-En Tien